Vagus nerve stimulation therapy (VNST) in epilepsy - implications for dental practice.

Source

King's College London Dental Institute, Department of Community Special Care Dentistry, King's College London, Denmark Hill Campus, Bessemer Road, SE5 9RW.

Abstract

Epilepsy is a chronic condition which affects about 1% of the population. It is important that the dental team is aware of the management of epileptic seizures and epileptic syndromes including recent advances in seizure management. As people with epilepsy often get a warning aura before seizures begin, the management of the condition has increasingly involved measures to prevent the seizure, once the aura has begun. Vagus nerve stimulation therapy (VNST) in epilepsy involves the use of an implantable electronic device and is being increasingly used in the UK to control severe treatment resistant epilepsy. As a result, more patients will be presented to clinicians in the primary healthcare setting and hospital services with these devices in place. Members of the dental team need to understand the principles of epilepsy control, how VNST is used in the management of intractable epilepsy, how the VNST system operates and the implications of VNST use for dental practice including medical devices, interactions and safety features.

PMID:: 22281628; [PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/22281628